|
TOP 20 cited articlesin Medicine
(2006—2010)
1. Cancer statistics, 2007
Jemal, A. (2007), Ca-A Cancer Journal for Clinicians, Volume 57, Issue 1, Pages 43-66 Cited by: 3,460
2. Cancer statistics, 2006
Jemal, A. (2006), Ca-A Cancer Journal for Clinicians, Volume 56, Issue 2, Pages 106-130 Cited by: 2,970
3. Cancer statistics, 2008
Jemal, A. (2008), CA Cancer Journal for Clinicians, Volume 58, Issue 2, Pages 71-96 Cited by: 2,969
4. Prevalence of overweight and obesity in the United States, 1999-2004
Ogden, C.L. (2006), Journal of the American Medical Association, Volume 295, Issue 13, Pages 1549-1555 Cited by: 2,840
5. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0
Tamura, K. (2007), Molecular Biology and Evolution, Volume 24, Issue 8, Pages 1596-1599 Cited by: 2,618
6. Heart disease and stroke statistics - 2006 Update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Thom, T. (2006), Circulation, Volume 113, Issue 6, Pages e85-e151 Cited by: 1,175
7. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes
Nissen, S.E. (2007), New England Journal of Medicine, Volume 356, Issue 24, Pages 2457-2471 Cited by: 1,137
8. Intensive insulin therapy in the medical ICU
Van Den Berghe, G. (2006), New England Journal of Medicine, Volume 354, Issue 5, Pages 449-461 Cited by: 1,115
9. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
Motzer, R.J. (2007), New England Journal of Medicine, Volume 356, Issue 2, Pages 115-124 Cited by: 1,037
10. Heart disease and stroke statistics - 2007 Update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Rosamond, W. (2007), Circulation, Volume 115, Issue 5, Pages e69-e171 Cited by: 1,033
11. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
Mancia, G. (2007), Journal of Hypertension, Volume 25, Issue 6, Pages 1105-1187 Cited by: 975
12. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
Bonner, J.A. (2006), New England Journal of Medicine, Volume 354, Issue 6, Pages 567-578 Cited by: 974
13. Sorafenib in advanced clear-cell renal-cell carcinoma
Escudier, B. (2007), New England Journal of Medicine, Volume 356, Issue 2, Pages 125-134 Cited by: 972
14. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer
Sandler, A. (2006), New England Journal of Medicine, Volume 355, Issue 24, Pages 2542-2550 Cited by: 946
15. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells
Veldhoen, M. (2006), Immunity, Volume 24, Issue 2, Pages 179-189 Cited by: 883
16. Heart disease and stroke statistics-2008 Update: A report from the American heart association statistics committee and stroke statistics subcommittee
Rosamond, W. (2008), Circulation, Volume 117, Issue 4, Pages e25-e46 Cited by: 799
17. Standards of medical care in diabetes - 2006
null (2006), Diabetes Care, Volume 29, Issue SUPPL. 1, Pages S4-S42 Cited by: 780
18. Effects of intensive glucose lowering in type 2 diabetes
Friedewald, W.T. (2008), New England Journal of Medicine, Volume 358, Issue 24, Pages 2545-2559 Cited by: 778
19. Medical progress: Vitamin D deficiency
Holick, M.F. (2007), New England Journal of Medicine, Volume 357, Issue 3, Pages 266-281 Cited by: 758
20. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
Miyakis, S. (2006), Journal of Thrombosis and Haemostasis, Volume 4, Issue 2, Pages 295-306 Cited by: 731
TOP 20 cited articlesin Neuroscience
(2006—2010)
1. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: A statement for healthcare professionals from the American Heart Association/American Stroke Association council on stroke - Co-sponsored by the council on cardiovascular radiology and intervention. The American Academy of Neurology affirms the value of this guideline
Sacco, R.L. (2006), Stroke, Volume 37, Issue 2, Pages 577-617 Cited by: 420
2. A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R.S. (2006), Biological Psychiatry, Volume 59, Issue 12, Pages 1116-1127 Cited by: 386
3. The 2007 WHO classification of tumours of the central nervous system
Louis, D.N. (2007), Acta Neuropathologica, Volume 114, Issue 2, Pages 97-109 Cited by: 369
4. Meeting of minds: The medial frontal cortex and social cognition
Amodio, D.M. (2006), Nature Reviews Neuroscience, Volume 7, Issue 4, Pages 268-277 Cited by: 366
5. Neural mechanisms of addiction: The role of reward-related learning and memory
Hyman, S.E. (2006), Annual Review of Neuroscience, Volume 29, Issue null, Pages 565-598 Cited by: 363
6. The precuneus: A review of its functional anatomy and behavioural correlates
Cavanna, A.E. (2006), Brain, Volume 129, Issue 3, Pages 564-583 Cited by: 314
7. Revised diagnostic criteria for neuromyelitis optica
Wingerchuk, D.M. (2006), Neurology, Volume 66, Issue 10, Pages 1485-1489 Cited by: 312
8. Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration
Spaide, R.F. (2006), Retina, Volume 26, Issue 4, Pages 383-390 Cited by: 301
9. Oxidative stress and neurodegeneration: Where are we now?
Halliwell, B. (2006), Journal of Neurochemistry, Volume 97, Issue 6, Pages 1634-1658 Cited by: 290
10. Astrocyte-endothelial interactions at the blood-brain barrier
Abbott, N.J. (2006), Nature Reviews Neuroscience, Volume 7, Issue 1, Pages 41-53 Cited by: 287
11. Adult neurogenesis and functional plasticity in neuronal circuits
Lledo, P.-M. (2006), Nature Reviews Neuroscience, Volume 7, Issue 3, Pages 179-193 Cited by: 283
12. Microglia-mediated neurotoxicity: Uncovering the molecular mechanisms
Block, M.L. (2007), Nature Reviews Neuroscience, Volume 8, Issue 1, Pages 57-69 Cited by: 268
13. Repetition and the brain: Neural models of stimulus-specific effects
Grill-Spector, K. (2006), Trends in Cognitive Sciences, Volume 10, Issue 1, Pages 14-23 Cited by: 266
14. TRPA1 Contributes to Cold, Mechanical, and Chemical Nociception but Is Not Essential for Hair-Cell Transduction
Kwan, K.Y. (2006), Neuron, Volume 50, Issue 2, Pages 277-289 Cited by: 261
15. Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging
Fox, M.D. (2007), Nature Reviews Neuroscience, Volume 8, Issue 9, Pages 700-711 Cited by: 250
16. Guidelines for the early management of adults with ischemic stroke: A guideline from the American heart association/American stroke association stroke council, clinical cardiology council, cardiovascular radiology and intervention council, and the atherosclerotic peripheral vascular disease and quality of care outcomes in research interdisciplinary working groups:
Adams Jr., H.P. (2007), Stroke, Volume 38, Issue 5, Pages 1655-1711 Cited by: 244
17. Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment
Breivik, H. (2006), European Journal of Pain, Volume 10, Issue 4, Pages 287-333 Cited by: 241
18. Aβ oligomers - A decade of discovery
Walsh, D.M. (2007), Journal of Neurochemistry, Volume 101, Issue 5, Pages 1172-1184 Cited by: 240
19. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action
Tsankova, N.M. (2006), Nature Neuroscience, Volume 9, Issue 4, Pages 519-525 Cited by: 238
20. Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data
Smith, S.M. (2006), NeuroImage, Volume 31, Issue 4, Pages 1487-1505 Cited by: 236
TOP 20 cited articles in Health Professions
(2006 - 2010)
1. First performance evaluation of a dual-source CT (DSCT) system
Flohr, T.G. (2006), European Radiology, Volume 16, Issue 2, Pages 256-268 Cited by: 413
2. Physical activity and public health: Updated recommendation for adults from the American College of Sports Medicine and the American Heart Association
Haskell, W.L. (2007), Medicine and Science in Sports and Exercise, Volume 39, Issue 8, Pages 1423-1434 Cited by: 350
3. Nephrogenic systemic fibrosis: Risk factors and incidence estimation
Sadowski, E.A. (2007), Radiology, Volume 243, Issue 1, Pages 148-157 Cited by: 295
4. Gadodiamide-associated nephrogenic systemic fibrosis: Why radiologists should be concerned
Broome, D.R. (2007), American Journal of Roentgenology, Volume 188, Issue 2, Pages 586-592 Cited by: 271
5. Accuracy of dual-source CT coronary angiography: First experience in a high pre-test probability population without heart rate control
Scheffel, H. (2006), European Radiology, Volume 16, Issue 12, Pages 2739-2747 Cited by: 200
6. Diagnostic accuracy of non-invasive 64-slice CT coronary angiography in patients with stable angina pectoris
Pugliese, F. (2006), European Radiology, Volume 16, Issue 3, Pages 575-582 Cited by: 195
7. Gastrointestinal stromal tumors: Review on morphology, molecular pathology, prognosis, and differential diagnosis
Miettinen, M. (2006), Archives of Pathology and Laboratory Medicine, Volume 130, Issue 10, Pages 1466-1478 Cited by: 191
8. Dual-source CT cardiac imaging: Initial experience
Johnson, T.R.C. (2006), European Radiology, Volume 16, Issue 7, Pages 1409-1415 Cited by: 182
9. Integrated PET/CT: Current applications and future directions
Von Schulthess, G.K. (2006), Radiology, Volume 238, Issue 2, Pages 405-422 Cited by: 162
10. Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis
Kuo, P.H. (2007), Radiology, Volume 242, Issue 3, Pages 647-649 Cited by: 159
11. Evidence for prescribing exercise as therapy in chronic disease
Pedersen, B.K. (2006), Scandinavian Journal of Medicine and Science in Sports, Volume 16, Issue SUPPL. 1, Pages 3-63 Cited by: 152
12. Physical activity in the United States measured by accelerometer
Troiano, R.P. (2008), Medicine and Science in Sports and Exercise, Volume 40, Issue 1, Pages 181-188 Cited by: 150
13. Material differentiation by dual energy CT: Initial experience
Johnson, T.R.C. (2007), European Radiology, Volume 17, Issue 6, Pages 1510-1517 Cited by: 148
14. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
Wolff, A.C. (2007), Archives of Pathology and Laboratory Medicine, Volume 131, Issue 1, Pages 18-43 Cited by: 146
15. Accuracy of 64-MDCT in the diagnosis of ischemic heart disease
Nikolaou, K. (2006), American Journal of Roentgenology, Volume 187, Issue 1, Pages 111-117 Cited by: 146
16. Sparse MRI: The application of compressed sensing for rapid MR imaging
Lustig, M. (2007), Magnetic Resonance in Medicine, Volume 58, Issue 6, Pages 1182-1195 Cited by: 144
17. Physical activity and public health in older adults: Recommendation from the American College of Sports Medicine and the American Heart Association
Nelson, M.E. (2007), Medicine and Science in Sports and Exercise, Volume 39, Issue 8, Pages 1435-1445 Cited by: 144
18. ESPEN Guidelines on Enteral Nutrition: Intensive care
Kreymann, K.G. (2006), Clinical Nutrition, Volume 25, Issue 2, Pages 210-223 Cited by: 139
19. Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials
Shankar, L.K. (2006), Journal of Nuclear Medicine, Volume 47, Issue 6, Pages 1059-1066 Cited by: 138
20. American College of Radiology White Paper on Radiation Dose in Medicine
Amis Jr., E.S. (2007), JACR Journal of the American College of Radiology, Volume 4, Issue 5, Pages 272-284 Cited by: 135
TOP 20 cited articles in Nursing
(2006—2010)
1. Pathology of Drug-Eluting Stents in Humans. Delayed Healing and Late Thrombotic Risk
Joner, M. (2006), Journal of the American College of Cardiology, Volume 48, Issue 1, Pages 193-202 Cited by: 575
2. Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting Stents. An Observational Study of Drug-Eluting Versus Bare-Metal Stents
Pfisterer, M. (2006), Journal of the American College of Cardiology, Volume 48, Issue 12, Pages 2584-2591 Cited by: 530
3. Standards of medical care in diabetes-2009
null (2009), Diabetes Care, Volume 32, Issue SUPPL. 1, Pages S13-S61 Cited by: 293
4. ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 Appropriateness Criteria for Cardiac Computed Tomography and Cardiac Magnetic Resonance Imaging* * Developed in accordance with the principles and methodology outlined by ACCF: Patel MR, Spertus JA, Brindis RG, Hendel RC, Douglas PS, Peterson ED, Wolk MJ, Allen JM, Raskin IE.
Hendel, R.C. (2006), Journal of the American College of Cardiology, Volume 48, Issue 7, Pages 1475-1497 Cited by: 290
5. ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease)
Bonow, R.O. (2006), Journal of the American College of Cardiology, Volume 48, Issue 3, Pages e1-e148 Cited by: 271
6. Pathology of the Vulnerable Plaque
Virmani, R. (2006), Journal of the American College of Cardiology, Volume 47, Issue 8 SUPPL., Pages C13-C18 Cited by: 259
7. Accuracy of 64-slice computed tomography to classify and quantify plaque volumes in the proximal coronary system: A comparative study using intravascular ultrasound
Leber, A.W. (2006), Journal of the American College of Cardiology, Volume 47, Issue 3, Pages 672-677 Cited by: 254
8. ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction)...
Anderson, J.L. (2007), Journal of the American College of Cardiology, Volume 50, Issue 7, Pages e1-e157 Cited by: 253
9. The human obesity gene map: The 2005 update
Rankinen, T. (2006), Obesity, Volume 14, Issue 4, Pages 529-644 Cited by: 240
10. Impact of Platelet Reactivity After Clopidogrel Administration on Drug-Eluting Stent Thrombosis
Buonamici, P. (2007), Journal of the American College of Cardiology, Volume 49, Issue 24, Pages 2312-2317 Cited by: 228
11. Worldwide trends in childhood overweight and obesity.
Wang, Y. (2006), International journal of pediatric obesity : IJPO : an official journal of the International Association for the Study of Obesity, Volume 1, Issue 1, Pages 11-25 Cited by: 228
12. Metabolic Syndrome and Risk of Incident Cardiovascular Events and Death. A Systematic Review and Meta-Analysis of Longitudinal Studies
Gami, A.S. (2007), Journal of the American College of Cardiology, Volume 49, Issue 4, Pages 403-414 Cited by: 226
13. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: The role of dual drug resistance
Lev, E.I. (2006), Journal of the American College of Cardiology, Volume 47, Issue 1, Pages 27-33 Cited by: 224
14. Late Thrombosis of Drug-Eluting Stents: A Meta-Analysis of Randomized Clinical Trials
Bavry, A.A. (2006), American Journal of Medicine, Volume 119, Issue 12, Pages 1056-1061 Cited by: 215
15. Influence of Omeprazole on the Antiplatelet Action of Clopidogrel Associated With Aspirin. The Randomized, Double-Blind OCLA (Omeprazole CLopidogrel Aspirin) Study
Gilard, M. (2008), Journal of the American College of Cardiology, Volume 51, Issue 3, Pages 256-260 Cited by: 213
16. Treatment of calcific aortic stenosis with the percutaneous heart valve: Mid-term follow-up from the initial feasibility studies: The French experience
Cribier, A. (2006), Journal of the American College of Cardiology, Volume 47, Issue 6, Pages 1214-1223 Cited by: 213
17. Impact of the Degree of Peri-Interventional Platelet Inhibition After Loading With Clopidogrel on Early Clinical Outcome of Elective Coronary Stent Placement
Hochholzer, W. (2006), Journal of the American College of Cardiology, Volume 48, Issue 9, Pages 1742-1750 Cited by: 210
18. Hypersensitivity cases associated with drug-eluting coronary stents: A review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project
Nebeker, J.R. (2006), Journal of the American College of Cardiology, Volume 47, Issue 1, Pages 175-181 Cited by: 209
19. A Randomized Comparison of High Clopidogrel Loading Doses in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes. The ALBION (Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis) Trial
Montalescot, G. (2006), Journal of the American College of Cardiology, Volume 48, Issue 5, Pages 931-938 Cited by: 205
20. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation-Executive Summary. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation)
Fuster, V. (2006), Journal of the American College of Cardiology, Volume 48, Issue 4, Pages 854-906 Cited by: 205
TOP 20 cited articles in Pharmacology, Toxicology and Pharmaceutics
(2006—2010)
1. Free radicals, metals and antioxidants in oxidative stress-induced cancer
Valko, M. (2006), Chemico-Biological Interactions, Volume 160, Issue 1, Pages 1-40 Cited by: 546
2. Anticancer activities of histone deacetylase inhibitors
Bolden, J.E. (2006), Nature Reviews Drug Discovery, Volume 5, Issue 9, Pages 769-784 Cited by: 473
3. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
Dominici, M. (2006), Cytotherapy, Volume 8, Issue 4, Pages 315-317 Cited by: 471
4. Natural products as sources of new drugs over the last 25 years
Newman, D.J. (2007), Journal of Natural Products, Volume 70, Issue 3, Pages 461-477 Cited by: 409
5. Therapeutic potential of resveratrol: The in vivo evidence
Baur, J.A. (2006), Nature Reviews Drug Discovery, Volume 5, Issue 6, Pages 493-506 Cited by: 405
6. The 2005 World Health Organization reevaluation of human and mammalian toxic equivalency factors for dioxins and dioxin-like compounds
Van den Berg, M. (2006), Toxicological Sciences, Volume 93, Issue 2, Pages 223-241 Cited by: 361
7. Angiogenesis: An organizing principle for drug discovery?
Folkman, J. (2007), Nature Reviews Drug Discovery, Volume 6, Issue 4, Pages 273-286 Cited by: 359
8. Guide to Receptors and Channels (GRAC), 3rd edition
Alexander, S.P.H. (2008), British Journal of Pharmacology, Volume 153, Issue SUPPL. 2, Pages S1-S196 Cited by: 346
9. The endocannabinoid system as an emerging target of pharmacotherapy
Pacher, P. (2006), Pharmacological Reviews, Volume 58, Issue 3, Pages 389-462 Cited by: 337
10. Targeting multidrug resistance in cancer
Szakács, G. (2006), Nature Reviews Drug Discovery, Volume 5, Issue 3, Pages 219-234 Cited by: 315
11. Molecular targets of dietary agents for prevention and therapy of cancer
Aggarwal, B.B. (2006), Biochemical Pharmacology, Volume 71, Issue 10, Pages 1397-1421 Cited by: 298
12. Therapeutic potential of toll-like receptor 9 activation
Krieg, A.M. (2006), Nature Reviews Drug Discovery, Volume 5, Issue 6, Pages 471-484 Cited by: 294
13. Epigenetic therapy of cancer: Past, present and future
Yoo, C.B. (2006), Nature Reviews Drug Discovery, Volume 5, Issue 1, Pages 37-50 Cited by: 288
14. Adenosine receptors as therapeutic targets
Jacobson, K.A. (2006), Nature Reviews Drug Discovery, Volume 5, Issue 3, Pages 247-264 Cited by: 263
15. Cyclic nucleotide phosphodiesterases: Molecular regulation to clinical use
Bender, A.T. (2006), Pharmacological Reviews, Volume 58, Issue 3, Pages 488-520 Cited by: 226
16. How many drug targets are there?
Overington, J.P. (2006), Nature Reviews Drug Discovery, Volume 5, Issue 12, Pages 993-996 Cited by: 224
17. Lab-on-a-chip: Microfluidics in drug discovery
Dittrich, P.S. (2006), Nature Reviews Drug Discovery, Volume 5, Issue 3, Pages 210-218 Cited by: 224
18. Organocatalytic asymmetric conjugate additions
Almaşi, D. (2007), Tetrahedron Asymmetry, Volume 18, Issue 3, Pages 299-365 Cited by: 220
19. Transition metal catalyzed oxidative functionalization of carbon-hydrogen bonds
Dick, A.R. (2006), Tetrahedron, Volume 62, Issue 11, Pages 2439-2463 Cited by: 212
20. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
Owens III, D.E. (2006), International Journal of Pharmaceutics, Volume 307, Issue 1, Pages 93-102 Cited by: 211
|
